DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
George S, Wang Q, Heinrich MC et al.
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
J Clin Oncol 2012;
30: 2401-2407
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.